Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis

American Journal of Nephrology

Volumn 32, Issue 4, 2010, Pages 311-316

  Noureddine, Lama A ^a   Usman, Sohail A ^a   Yu, Zhangsheng ^a   Moorthi, Ranjani N ^a   Moe, Sharon M ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Diabetic nephropathy; Dialysis; Focal segmental glomerulosclerosis; Glomerulonephritis; Hepatitis C

Indexed keywords

CREATININE;

ADULT; AFRICAN AMERICAN; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK;

EID: 77955532272     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319456     Document Type: Article

References (23)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-714.
2. Burstein DM, Rodby RA: Membranoprolif-erative glomerulonephritis associated with hepatitis C virus infection. J Am Soc Nephrol 1993; 4:1288-1293.
3. Doutrelepont JM, Adler M, Willems M, Du-rez P, Yap SH: Hepatitis C infection and membranoproliferative glomerulonephritis. Lancet 1993; 341: 317.
4. Johnson RJ, Gretch DR, Yamabe H, et al: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328:465-470.
5. Gopalani A, Ahuja TS: Prevalence of glomer-ulopathies in autopsies of patients infected with the hepatitis C virus. Am J Med Sci 2001; 322: 57-60.
6. Motta M, Malaguarnera M, Restuccia N, Romano M, Vinci E, Pistone G: Focal segmental glomerulosclerosis and hepatitis C virus: a case report. Panminerva Med 2001; 43:49-52.
7. Stehman-Breen C, Alpers CE, Fleet WP, Johnson RJ: Focal segmental glomerular sclerosis among patients infected with hepatitis C virus. Nephron 1999; 81 : 37-40.
8. Jadoul M, Poignet JL, Geddes C, et al: The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 2004; 19: 904-909.
9. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl 2008; 109:S1-S99.
10. Moe SM, Pampalone AJ, Ofner S, Rosenman M, Teal E, Hui SL: Association of hepatitis C virus infection with prevalence and development of kidney disease. Am J Kidney Dis 2008; 51: 885-892.
11. Tsui JI, Vittinghoff E, Shlipak MG, O'Hare AM: Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2006; 17: 116 8-1174 .
12. Tsui JI, Vittinghoff E, Shlipak MG, et al: Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med 20 07; 16 7: 1271-1276.
13. Dalrymple LS, Koepsell T, Sampson J, et al: Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol 2007; 2:715-721.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
15. Kasuno K, Ono T, Matsumori A, et al: Hepatitis C virus-associated tubulointerstitial injury. Am J Kidney Dis 2003; 41:767-775.
16. Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F: Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobuline-mic membranoproliferative glomerulone-phritis. Hepatology 1997; 25:1237-1244.
17. Sansonno D, Lauletta G, Montrone M, Gran-daliano G, Schena FP, Dammacco F: Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol 2005; 140:498-506.
18. Alpers CE, Smith KD: Cryoglobulinemia and renal disease. Curr Opin Nephrol Hy-pertens 2008; 17:243-249.
19. Martin M, Sole M: Membranoproliferative glomerulonephritis associated with hepatitis C infection. J Hepatol 2004; 41:881.
20. Fischer MJ, Wyatt CM, Gordon K, et al: Hepatitis C and the risk of kidney disease and mortality in veterans with HIV. J Acquir Immune Defic Syndr 2010; 53: 222-226.
21. Crook ED, Penumalee S, Gavini B, Filippova K: Hepatitis C is a predictor of poorer renal survival in diabetic patients. Diabetes Care 2005; 28:2187-2191.
22. Soma J, Saito T, Taguma Y, et al: High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related ne-phropathy. J Am Soc Nephrol 2000; 11:690-699.
23. Ghany MG, Strader DB, Thomas DL, Seeff LB: Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374.